Kevin L. Russell, Richard E. Rupp, Javier O. Morales-Ramirez, Clemente Diaz-Perez, Charles P. Andrews, Andrew W. Lee, . . . Beth-Ann G. Coller. (2022). A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults. Taylor & Francis Group.
Chicago Style (17th ed.) CitationKevin L. Russell, et al. A Phase I Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Live-attenuated Quadrivalent Dengue Vaccine in Flavivirus-naïve and Flavivirus-experienced Healthy Adults. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationKevin L. Russell, et al. A Phase I Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Live-attenuated Quadrivalent Dengue Vaccine in Flavivirus-naïve and Flavivirus-experienced Healthy Adults. Taylor & Francis Group, 2022.